东吴证券股份有限公司 关于宁波索宝蛋白科技股份有限公司 使用暂时闲置募集资金进行现金管理及 以协定存款方式存放募集资金余额的核查意见 东吴证券股份有限公司（以下简称"东吴证券"或"保荐人"）作为宁波索宝 蛋白科技股份有限公司（以下简称"索宝蛋白"或"公司"）首次公开发行股票并 在上海证券交易所主板上市的保荐人，根据《上市公司募集资金监管规则》《上 海证券交易所上市公司自律监管指引第 1 号——规范运作》《上海证券交易所上 市公司自律监管指引第 11 号——持续督导》等规定中关于上市公司募集资金使 用的有关规定，对索宝蛋白使用暂时闲置募集资金进行现金管理及以协定存款 方式存放募集资金余额的事项进行了审慎核查，并出具核查意见如下： 一、投资情况概述 2、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意宁波索宝蛋白科技股份有 限公司首次公开发行股票注册的批复》（证监许可[2023]1851 号），同意公司首 次公开发行股票的注册申请，并经上海证券交易所同意，公司于 2023 年 12 月 15 日首次向社会公众公开发行人民币普通股（A 股）4,786.48 万股，发行价格 为每股人民币 21.29 元， ...

证券代码：603231 证券简称：索宝蛋白 公告编号：2025-034 宁波索宝蛋白科技股份有限公司 关于使用暂时闲置募集资金进行现金管理及以协定 存款方式存放募集资金余额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资种类：投资产品为安全性高、流动性好、低风险的保本型现金管 理产品，包括但不限于结构性存款、定期存款、通知存款等。不得影响募集 资金投资计划正常进行，且该投资产品不得用于质押，不属于国家明令禁止 的类型。 投资金额：最高额度不超过人民币 55,000 万元（含本数），额度范围 内可滚动使用。 已履行及拟履行的审议程序：宁波索宝蛋白科技股份有限公司（以下 简称"索宝蛋白"或"公司"）于 2025 年 11 月 17 日召开第三届董事会第六 次会议，审议通过了《关于使用暂时闲置募集资金进行现金管理及以协定存 款方式存放募集资金余额的议案》，同意公司及子公司在确保不影响募集资金 投资项目建设和募集资金使用的情况下，使用最高额度不超过人民币 5.50 亿 元（含本数）的暂时闲置募集资金进行现金 ...

北京市朝阳区建外大街丁 12 号英皇集团中心 8、9、11 层 8/9/11/F, Emperor Group Centre, No.12D, Jianwai Avenue, Chaoyang District, Beijing, 100022, P.R.China 电话/Tel.: 010-50867666 传真/Fax: 010-56916450 网址/Website: www.kangdalawyers.com 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 南昌 北京市康达律师事务所 关于宁波索宝蛋白科技股份有限公司 2025 年第一次临时股东大会的 法 律 意 见 书 康达股会字【2025】第 0487 号 致：宁波索宝蛋白科技股份有限公司 北京市康达律师事务所（以下简称"本所"）接受宁波索宝蛋白科技股份有限公 司（以下简称"公司"）的委托，指派本所律师参加公司 2025 年第一次临时股东大 会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和 ...

证券代码：603231 证券简称：索宝蛋白 公告编号：2025-032 宁波索宝蛋白科技股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 二、 议案审议情况 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 11 月 17 日 (二)股东大会召开的地点：山东省东营市垦利区华丰路 23 号山东万得福生物科 技有限公司办公楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 97 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 95,655,556 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 49.9613 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，会议由董事长刘季善先生主持。会议采取 现场投票与网络投 ...

证券代码：603231 证券简称：索宝蛋白 公告编号：2025-033 宁波索宝蛋白科技股份有限公司 第三届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 任。 宁波索宝蛋白科技股份有限公司（以下简称"公司"）第三届董事会第六次 会议于 2025 年 11 月 12 日以邮件等方式发出会议通知和材料，并于 2025 年 11 月 17 日在公司会议室以现场结合通讯表决方式召开会议。会议应出席董事 6 名， 实际出席 6 名，会议由董事长刘季善先生主持召开，高级管理人员列席会议。会 议召开符合法律法规、《公司法》及《公司章程》的规定，会议决议合法、有效。 会议审议通过以下议案： （一）审议通过《关于开立募集资金专项账户并签订募集资金四方监管协议 的议案》 特此公告。 宁波索宝蛋白科技股份有限公司董事会 2025 年 11 月 18 日 （二）审议通过《关于使用暂时闲置募集资金进行现金管理及以协定存款方 式存放募集资金余额的议案》 同意在确保不影响募集资金投资项目建设和募集资金使用的情况下，使用最 高额度不超 ...

Group 1 - The core point of the article is that Suobao Protein (SH 603231) held its third board meeting on November 17, 2025, to discuss the establishment of a special fundraising account and sign a four-party supervision agreement for the raised funds [1] - For the fiscal year 2024, Suobao Protein's revenue composition is heavily weighted towards the agricultural and sideline food processing industry, accounting for 99.61% of total revenue, while other businesses contribute only 0.39% [1] - As of the report date, Suobao Protein has a market capitalization of 4 billion yuan [1]

Core Insights - The plant protein industry, particularly soybean protein, is experiencing rapid growth due to increasing awareness of health and nutrition, with the market size in China projected to reach 16.161 billion yuan in 2024, a year-on-year increase of 4.47% [1][10]. Overview - Protein is essential for life and is composed of amino acids, with 20 types in total. Among these, 8 are essential and must be obtained from food. Plant proteins, particularly from beans, are lower in cholesterol and saturated fats, making them suitable for individuals with liver diseases and for preventing cardiovascular diseases [2][4]. Industry Barriers - The soybean protein industry is subject to strict regulations and quality control measures, including licensing and traceability requirements. New entrants face high technical barriers due to the established production processes and technology of existing players [6][7]. Market Policies - The Chinese government has implemented various policies to enhance soybean self-sufficiency and ensure quality control in soybean protein production. These policies promote the development of the soybean industry and require strict adherence to safety and quality standards [8]. Industry Chain - The soybean protein industry encompasses upstream activities such as soybean cultivation and procurement, midstream production, and downstream applications in various sectors including meat processing, snacks, dairy, and pharmaceuticals. The cost structure indicates that direct materials account for over 60% of production costs, with soybean being the primary raw material [8][9]. Current Development - Soybean is recognized for its high protein content and nutritional value, with various health benefits including cholesterol reduction and improved gut health. The domestic market for soybean protein is maturing rapidly, with significant growth in applications across multiple sectors [10][11]. Competitive Landscape - The soybean protein industry in China has seen the emergence of several key players, including Shandong Yuwang Ecological Food Co., Ltd., and Ningbo Suobao Protein Technology Co., Ltd. These companies are expanding their product offerings and market presence [11][12]. Future Trends - The soybean protein industry is shifting towards high-end products, with increasing production of high-purity and organized proteins. Innovations in processing technologies are expected to enhance the application of soybean protein in emerging fields such as pharmaceuticals and 3D printing [14][15].

Group 1 - The core viewpoint of the article is that Haitong International has given a "better than market" rating to Suobao Protein (603231.SH) based on its strong financial performance and growth prospects [1] Group 2 - Revenue showed steady growth in the first three quarters, with significant profit expansion [1] - In the third quarter, revenue accelerated, leading to faster profit growth [1] - The company is expanding its overseas market presence, with noticeable effects in cost reduction and efficiency improvement [1]

Group 1 - Company plans to repurchase shares worth between 50 million to 100 million yuan at a price not exceeding 14.00 yuan per share to reduce registered capital [1] - Company is engaged in investment operations, environmental engineering EPC, water treatment equipment production and sales, and water environment design consulting [1] Group 2 - Company announced a change in its joint venture investment project to a "100,000 tons/year waste rubber green low-carbon recycling preparation of carbon-based new materials project" with a total investment of 88 million yuan for the first phase [2][3] Group 3 - Company received an administrative regulatory measure decision from the Beijing Securities Regulatory Commission due to the failure to timely disclose the judicial freeze of shares [4] - The controlling shareholder's shares were frozen, accounting for 13.9% of the total share capital [4] Group 4 - Company is in the product development stage for its embodied intelligent robot business, which has not yet achieved mass production or revenue generation [5][6] Group 5 - Shareholders plan to reduce their holdings by up to 2.98% of the company's total shares through various trading methods [7][8] - Company specializes in the research, design, manufacturing, and sales of material handling equipment [9] Group 6 - Shareholders plan to reduce their holdings by up to 3% of the company's total shares [10][11] Group 7 - Shareholders plan to reduce their holdings by up to 1% of the company's total shares [12][18] Group 8 - Company announced the receipt of a property with an estimated value of 133 million yuan, which is expected to increase pre-tax profits by approximately 130 million yuan for the 2025 fiscal year [17][18] Group 9 - Company announced that its main product, phosphorus trichloride, is primarily used in the production of water treatment agents [19] - The company is facing risks related to the administrative approval process for a project that is behind schedule [19] Group 10 - Controlling shareholders plan to reduce their holdings by up to 3.66% of the company's total shares [20][21] Group 11 - Company signed a strategic framework agreement with a robotics company to collaborate on applications in intelligent manufacturing [22] Group 12 - Company plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [23] Group 13 - Controlling shareholder plans to transfer 5% of the company's shares as part of a cash acquisition arrangement [24] Group 14 - Company announced a change in control with a new controlling party following a share transfer agreement [25] Group 15 - Company plans to transfer 60% of its subsidiary's equity at a base price of 1.6756 million yuan, which is expected to reduce net profit by approximately 26.4 million yuan for the 2025 fiscal year [26] Group 16 - Major shareholder plans to provide a loan of up to 1.666 billion yuan to the company for debt repayment purposes [27]

Mergers and Acquisitions - DingTong Technology plans to acquire 70% stake in Blue Ocean Vision for 126 million yuan, making it a subsidiary after the transaction [1] - Dongfang Zhizao intends to purchase 70% stake in Nantong Saifu Machinery Equipment for 27.4887 million yuan using its own funds [3] Shareholding Changes - Sobor Protein's shareholder Jinan Fosun and its concerted parties plan to reduce their holdings by up to 574.38 thousand shares, representing 3% of the total share capital [4] - Hetai Electromechanical's shareholder Hangzhou Haitai Jinghua plans to reduce its holdings by up to 195.98 thousand shares, accounting for 2.98% of the total share capital [5] - Hongtong Gas's shareholder Tian Hui intends to reduce his holdings by up to 848.64 thousand shares, which is not more than 3% of the total share capital [6] - Zhonggu Logistics's shareholder Ningbo Guyang Investment plans to reduce its holdings by up to 3% of the total share capital [7] Risk Matters - ST Chang Pharmaceutical faces a risk of delisting due to a cumulative price drop of 34.98% over two consecutive trading days, linked to an investigation by the Securities Regulatory Commission for suspected false financial reporting [8]